1-5 of 5
Yael Mamane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A004: Radiotherapy sensitizes preclinical models to DNA damage response agents

Pablo Binder, Theoni Katopodi, Lyndsey Hanson, Charlotte R. Bell, Eimear Flanagan, Paul Farrington, Nick Moore, Emily Wright, Yin Xin Ho, Tobias Bunday, Stewart Brown, Amy Cantrell, Yael Mamane, Jon Greenall, Shannon Sharman, John Woolley, Lorraine M. Mooney, Jane Kendrew
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6_Supplement): A004.
https://doi.org/10.1158/1538-8514.SYNTHLETH24-A004
Published: 10 June 2024
View article titled, Abstract A004: Radiotherapy sensitizes preclinical models to DNA damage response agents
Journal Articles

Abstract A003: Unwinding the complexities of helicases as compelling drug targets in oncology

Yael Mamane, Zoe Caple, Katie Chapman, Ian Henderson, Allan Jordan, Vanessa Lyne, Cynthia Okoye, Laurent Rigoreau, Ganesh Kadamur, Stuart Thomson, Chris Tomlinson, Jana Wolf
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6_Supplement): A003.
https://doi.org/10.1158/1538-8514.SYNTHLETH24-A003
Published: 10 June 2024
View article titled, Abstract A003: Unwinding the complexities of helicases as compelling drug targets in oncology
Journal Articles

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors

Anne Roulston, Michal Zimmermann, Robert Papp, Alexander Skeldon, Charles Pellerin, Émilie Dumas-Bérube, Valerie Dumais, Stéphane Dorich, Lee D. Fader, Sara Fournier, Li Li, Marie-Eve Leclaire, Shou Yun Yin, Amandine Chefson, Hunain Alam, William Yang, Chloe Fugère-Desjardins, Sabrina Vignini-Hammond, Kathryn Skorey, Amina Mulani, Victoria Rimkunas, Artur Veloso, Martine Hamel, Rino Stocco, Yael Mamane, Zuomei Li, Jordan T.F. Young, Michael Zinda, W. Cameron Black
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (2): 245–256.
https://doi.org/10.1158/1535-7163.MCT-21-0615
Published: 01 February 2022
View article titled, RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
Open the PDF for RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract P054: RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors

Anne Roulston, Michal Zimmerman, Robert Papp, Alex Skeldon, Charles Pellerin, Émilie Dumas-Bérube, Valerie Dumais, Stephane Dorich, Sara Fournier, Li Li, Marie-Ève Leclaire, Shou Yun Yin, Amandine Chefson, Hunain Alam, William Yang, Chloe Fugère-Desjardins, Sabrina Hammond, Kathryn Skorey, Amina Mulani, Victoria Rimkunas, Artur Veloso, Martine Hamel, Rino Stocco, Yael Mamane, Zuomei Li, Jordan Young, Mike Zinda, Cameron Black
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P054.
https://doi.org/10.1158/1535-7163.TARG-21-P054
Published: 01 December 2021
View article titled, Abstract P054: RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors
Journal Articles

Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target

Andrew Bier, Irene Oviedo-Landaverde, Jing Zhao, Yael Mamane, Mustapha Kandouz, Gerald Batist
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (4): 786–793.
https://doi.org/10.1158/1535-7163.MCT-08-0930
Published: 16 April 2009
View article titled, <em>Connexin43</em> pseudogene in breast cancer cells offers a novel therapeutic target
Open the PDF for <em>Connexin43</em> pseudogene in breast cancer cells offers a novel therapeutic target in another window